| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | SELL | SELL | SELL | NEUTRAL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.09▲ | 2.11▲ | 2.10▲ | 2.11▼ | 1.94▲ |
| MA10 | 2.08▲ | 2.11▲ | 2.12▼ | 2.26▼ | 1.70▲ |
| MA20 | 2.09▲ | 2.14▼ | 2.15▼ | 1.99▲ | 2.09▲ |
| MA50 | 2.10▲ | 2.15▼ | 2.16▼ | 1.68▲ | 4.86▼ |
| MA100 | 2.12▼ | 2.18▼ | 2.19▼ | 2.21▼ | 11.50▼ |
| MA200 | 2.16▼ | 2.15▼ | 1.74▲ | 4.70▼ | 24.26▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.002▲ | -0.005▼ | -0.008▼ | -0.010▼ | 0.224▲ |
| RSI | 56.645▲ | 46.990▼ | 47.080▼ | 55.393▲ | 42.160▼ |
| STOCH | 52.183 | 41.432 | 19.551▼ | 30.080 | 46.919 |
| WILL %R | -16.667▲ | -62.500 | -87.629▼ | -51.948 | -40.698 |
| CCI | 78.063 | -69.025 | -71.625 | -26.116 | 72.729 |
|
Thursday, January 29, 2026 03:12 PM
Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing pemvidutide to address serious liver diseases, announced the closing of its previously announced registered ...
|
|
Thursday, January 29, 2026 05:12 AM
The buyback program reflects management's confidence and its belief that the Company is substantially undervalued and represents a strategic deployment of ALT5 Sigma's strong balance sheet, which ...
|
|
Wednesday, January 28, 2026 07:58 AM
Altimmune Inc. (NASDAQ:ALT) shares dropped 6.2% in premarket trading on Wednesday after the biopharmaceutical company unveiled plans for a $75 million registered direct equity offering. The late-stage ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 30/01/26 | 2.11 | 2.21 | 2.05 | 2.10 | 3,008,214 |
| 29/01/26 | 2.32 | 2.578 | 2.10 | 2.15 | 6,509,027 |
| 28/01/26 | 2.22 | 2.248 | 2.075 | 2.12 | 2,340,127 |
| 27/01/26 | 2.02 | 2.21 | 2.00 | 2.19 | 2,980,226 |
| 26/01/26 | 2.13 | 2.17 | 1.98 | 1.99 | 3,422,431 |
| 23/01/26 | 2.30 | 2.32 | 2.05 | 2.19 | 4,128,663 |
| 22/01/26 | 2.50 | 2.5399 | 2.21 | 2.30 | 4,182,012 |
| 21/01/26 | 2.55 | 2.70 | 2.31 | 2.46 | 5,682,600 |
| 20/01/26 | 2.37 | 2.64 | 2.30 | 2.49 | 7,581,607 |
| 16/01/26 | 2.36 | 2.64 | 2.36 | 2.59 | 5,886,729 |
|
|
||||
|
|
||||
|
|